Continuous Regional Arterial Infusion Versus Intravenous Administration of Proteinase Inhibitor, Nafamostat Mesilate, for Predicted Severe Acute Pancreatitis: A Multicenter Randomized Open-label Trial
PANCREAS（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要